Pfizer Gross Profit 2006-2021 | PFE

Pfizer annual/quarterly gross profit history and growth rate from 2006 to 2021. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Pfizer gross profit for the quarter ending September 30, 2021 was $14.121B, a 70.75% increase year-over-year.
  • Pfizer gross profit for the twelve months ending September 30, 2021 was $45.185B, a 74.32% increase year-over-year.
  • Pfizer annual gross profit for 2020 was $33.216B, a 0.9% increase from 2019.
  • Pfizer annual gross profit for 2019 was $32.921B, a 3.4% increase from 2018.
  • Pfizer annual gross profit for 2018 was $31.838B, a 22.94% decline from 2017.
Pfizer Annual Gross Profit
(Millions of US $)
2020 $33,216
2019 $32,921
2018 $31,838
2017 $41,318
2016 $40,502
2015 $39,203
2014 $40,028
2013 $41,998
2012 $44,836
2011 $48,535
2010 $50,377
2009 $40,810
2008 $40,184
2007 $37,179
2006 $40,731
2005 $40,173
Pfizer Quarterly Gross Profit
(Millions of US $)
2021-09-30 $14,121
2021-06-30 $11,928
2021-03-31 $10,371
2020-12-31 $8,765
2020-09-30 $8,270
2020-06-30 $8,038
2020-03-31 $8,143
2019-12-31 $1,470
2019-09-30 $10,078
2019-06-30 $10,688
2019-03-31 $10,685
2018-12-31 $341
2018-09-30 $10,604
2018-06-30 $10,550
2018-03-31 $10,343
2017-12-31 $10,447
2017-09-30 $10,324
2017-06-30 $10,236
2017-03-31 $10,311
2016-12-31 $10,415
2016-09-30 $9,960
2016-06-30 $9,973
2016-03-31 $10,154
2015-12-31 $10,636
2015-09-30 $9,868
2015-06-30 $9,673
2015-03-31 $9,026
2014-12-31 $10,416
2014-09-30 $9,993
2014-06-30 $10,311
2014-03-31 $9,308
2013-12-31 $10,764
2013-09-30 $10,356
2013-06-30 $10,731
2013-03-31 $10,147
2012-12-31 $10,460
2012-09-30 $10,644
2012-06-30 $11,592
2012-03-31 $12,140
2011-12-31 $9,612
2011-09-30 $13,200
2011-06-30 $12,914
2011-03-31 $12,809
2010-12-31 $12,350
2010-09-30 $12,205
2010-06-30 $13,448
2010-03-31 $12,374
2009-12-31 $12,291
2009-09-30 $9,832
2009-06-30 $9,228
2009-03-31 $9,459
2008-12-31 $10,631
2008-09-30 $9,851
2008-06-30 $9,840
2008-03-31 $9,862
2007-12-31 $10,245
2007-09-30 $7,372
2007-06-30 $8,975
2007-03-31 $10,587
2006-12-31 $10,386
2006-09-30 $10,318
2006-06-30 $9,951
2006-03-31 $10,076
2005-12-31 $9,931
2005-09-30 $9,652
2005-06-30 $9,690
2005-03-31 $10,900
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $299.559B $41.908B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $449.095B 17.41
AbbVie (ABBV) United States $240.283B 11.05
Eli Lilly (LLY) United States $226.445B 28.08
Novo Nordisk (NVO) Denmark $224.742B 29.73
Merck (MRK) United States $203.541B 13.94
Novartis AG (NVS) Switzerland $190.436B 13.71
GlaxoSmithKline (GSK) United Kingdom $123.159B 15.00